CNO Stock Analysis: Buy, Sell, or Hold?
CNO - CNO Financial Group, Inc.
$52.52
1.06 (2.06%)
▲
5d:
+4.19%
30d:
+10.85%
90d:
+29.55%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jul 27, 2026
Get Alerted When CNO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CNO is fairly valued with market pricing in 4.1% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: CNO is fairly valued with market pricing in 4.1% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$64.75
Based on 7.3% avg growth
INTRINSIC VALUE TODAY
$40.20
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNO is currently trading at $52.52, which is considered extended relative to its 30-day fair value range of $46.39 to $50.31. From a valuation perspective, the stock is trading at a premium (Forward PE: 10.4) compared to its historical average (9.2). At these levels, the market is pricing in 4.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CNO is in a strong uptrend. The price is approaching resistance at $52.06. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CNO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CNO is in a strong uptrend. The price is approaching resistance at $52.06. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CNO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$46.39 -
$50.31
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
58.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($49.50)
- NEUTRAL: Market pricing in 4.1% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$46.39 -
$50.31
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$47.67
Resistance Level
$52.06
Current Trend
Strong Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.39
Wall Street Target
$49.50
(-3.8%)
Revenue Growth (YoY)
2.5%
Earnings Growth (YoY)
85.7%
Profit Margin
5.4%
Valuation Premium vs History
+4.1% premium
PE vs Historical
10.4 vs 9.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.1%
(market-implied from PE analysis)
1-Year Target
$53.57
(+4%)
2-Year Target
$55.77
(+8%)
3-Year Target
$58.05
(+13%)
3-Yr Target (if PE normalizes)
(PE: 10→9)
PE COMPRESSION
$51.42
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.6%)
$145.90
(+184%)
Base:
(SPY PE: 10.4, Growth: 10.6%)
$69.58
(+35%)
Bear:
(PE: 8.8, Growth: 10.6%)
$59.15
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 20.50 | Current EPS (TTM): $2.48
Bull Case
$111.69
(+117%)
Analyst growth 99.8%, PE expands to 22.6
Base Case
$101.54
(+97%)
Market implied 99.8%, PE stable at 20.5
Bear Case
$34.56
(-33%)
Severe decline -20.0%, PE contracts to 17.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 12:59 PM ET
Data refreshes hourly during market hours. Next update: 1:59 PM
Data refreshes hourly during market hours. Next update: 1:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Scott L Goldberg
SELL
11060 shares
2026-03-19
Gary C Bhojwani
SELL
43021 shares
2026-02-18
Matthew J Zimpfer
SELL
33800 shares
2026-02-18
Top Rated Insurance - Life Stocks
Top-rated stocks in Insurance - Life by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MET
MetLife Inc |
STRONG BUY
16 analysts |
$92 | 55 HOLD |
|
UNM
Unum Group |
BUY
13 analysts |
$98 | 63 BUY |
|
MFC
Manulife Financial Corp |
BUY
13 analysts |
$34 | 64 BUY |
|
ABL
Abacus Life Inc. |
STRONG BUY
5 analysts |
$14 | 58 HOLD |
|
GL
Globe Life Inc |
BUY
10 analysts |
$176 | 61 BUY |
